PortfoliosLab logo

Burning Rock Biotech Limited (BNR)

Equity · Currency in USD · Last updated Mar 21, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Burning Rock Biotech Limited in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,177 for a total return of roughly -88.23%. All prices are adjusted for splits and dividends.

BNR (Burning Rock Biotech Limited)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BNR

Burning Rock Biotech Limited


Burning Rock Biotech Limited had a return of 28.89% year-to-date (YTD) and -68.58% in the last 12 months. Over the past 10 years, Burning Rock Biotech Limited had an annualized return of -53.91%, while the S&P 500 had an annualized return of 9.94%, indicating that Burning Rock Biotech Limited did not perform as well as the benchmark.

1 month-6.45%-3.13%
6 months-10.49%2.02%
1 year-68.58%-11.46%
5 years (annualized)-53.91%9.94%
10 years (annualized)-53.91%9.94%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Burning Rock Biotech Limited Sharpe ratio is -0.70. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

BNR (Burning Rock Biotech Limited)
Benchmark (^GSPC)

Dividend History

Burning Rock Biotech Limited doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

BNR (Burning Rock Biotech Limited)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Burning Rock Biotech Limited. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Burning Rock Biotech Limited is 95.63%, recorded on Oct 24, 2022. The portfolio has not recovered from it yet.



To Bottom


To Recover



-95.63%Feb 23, 2021422Oct 24, 2022
-39.33%Jun 24, 202054Sep 9, 202089Jan 15, 2021143
-25.28%Jan 22, 20214Jan 27, 202117Feb 22, 202121
-5.77%Jun 15, 20201Jun 15, 20203Jun 18, 20204
-1.38%Jan 20, 20211Jan 20, 20211Jan 21, 20212

Volatility Chart

Current Burning Rock Biotech Limited volatility is 55.85%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

BNR (Burning Rock Biotech Limited)
Benchmark (^GSPC)